Strattera, or atomoxetine, works differently than many other ADHD medications. It selectively inhibits the norepinephrine transporter (NET). This means it prevents the reuptake of norepinephrine, a neurotransmitter crucial for focus, attention, and alertness. Increased norepinephrine levels in the synaptic cleft prolong its effects on the brain.
Norepinephrine’s Role in Focus and Attention
Norepinephrine plays a significant role in several brain regions impacting attention and impulse control. By increasing norepinephrine availability, Strattera helps improve these functions in individuals with ADHD. This improved neurotransmission translates to better concentration, reduced impulsivity, and enhanced organization.
Other Brain Impacts
While primarily impacting norepinephrine, Strattera may also influence other neurotransmitter systems indirectly. However, its primary mechanism remains the selective inhibition of NET. This targeted action distinguishes it from stimulants, which affect both dopamine and norepinephrine.
